Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision: v3.4.3 was added as the latest update and Revision: v3.4.2 was removed. No changes to study content or data.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.4.2 is now displayed and the older government funding status notice (v3.4.1) has been removed. This is a minor administrative update that does not change study content, eligibility criteria, or results.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded a funding-status notice directing users to NIH/cc.gov and OPM status pages and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedAdds a glossary display and updates QC-related labels and versioning (Revision: v3.4.0, Last Update Submitted that Met QC Criteria, No FEAR Act Data); removes older wording/labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.